1. Defining the role of mesenchymal stromal cells on the regulation of matrix metalloproteinases in skeletal muscle cells.
- Author
-
Sassoli C, Nosi D, Tani A, Chellini F, Mazzanti B, Quercioli F, Zecchi-Orlandini S, and Formigli L
- Subjects
- Actins genetics, Actins metabolism, Animals, Cell Differentiation, Cell Movement, Cells, Cultured, Collagen Type I genetics, Collagen Type I metabolism, Culture Media, Conditioned pharmacology, Cytokines pharmacology, Fibroblasts cytology, Fibroblasts drug effects, Fibroblasts metabolism, Heterocyclic Compounds, 1-Ring pharmacology, Humans, Intercellular Signaling Peptides and Proteins pharmacology, Matrix Metalloproteinase 2 genetics, Matrix Metalloproteinase 9 genetics, Matrix Metalloproteinase Inhibitors pharmacology, Mice, Muscle Fibers, Skeletal drug effects, NIH 3T3 Cells, Sulfones pharmacology, Tissue Inhibitor of Metalloproteinase-1 genetics, Tissue Inhibitor of Metalloproteinase-1 metabolism, Tissue Inhibitor of Metalloproteinase-2 genetics, Tissue Inhibitor of Metalloproteinase-2 metabolism, Matrix Metalloproteinase 2 metabolism, Matrix Metalloproteinase 9 metabolism, Mesenchymal Stem Cells metabolism, Muscle Fibers, Skeletal metabolism
- Abstract
Recent studies indicate that mesenchymal stromal cell (MSC) transplantation improves healing of injured and diseased skeletal muscle, although the mechanisms of benefit are poorly understood. In the present study, we investigated whether MSCs and/or their trophic factors were able to regulate matrix metalloproteinase (MMP) expression and activity in different cells of the muscle tissue. MSCs in co-culture with C2C12 cells or their conditioned medium (MSC-CM) up-regulated MMP-2 and MMP-9 expression and function in the myoblastic cells; these effects were concomitant with the down-regulation of the tissue inhibitor of metalloproteinases (TIMP)-1 and -2 and with increased cell motility. In the single muscle fiber experiments, MSC-CM administration increased MMP-2/9 expression in Pax-7(+) satellite cells and stimulated their mobilization, differentiation and fusion. The anti-fibrotic properties of MSC-CM involved also the regulation of MMPs by skeletal fibroblasts and the inhibition of their differentiation into myofibroblasts. The treatment with SB-3CT, a potent MMP inhibitor, prevented in these cells, the decrease of α-smooth actin and type-I collagen expression induced by MSC-CM, suggesting that MSC-CM could attenuate the fibrogenic response through mechanisms mediated by MMPs. Our results indicate that growth factors and cytokines released by these cells may modulate the fibrotic response and improve the endogenous mechanisms of muscle repair/regeneration., (Copyright © 2014. Published by Elsevier Inc.)
- Published
- 2014
- Full Text
- View/download PDF